CALO', Valentina
 Distribuzione geografica
Continente #
NA - Nord America 4.858
EU - Europa 2.405
AS - Asia 783
SA - Sud America 14
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 8.071
Nazione #
US - Stati Uniti d'America 4.850
FI - Finlandia 568
IT - Italia 559
DE - Germania 468
CN - Cina 423
SG - Singapore 235
UA - Ucraina 229
GB - Regno Unito 135
IE - Irlanda 113
SE - Svezia 87
BE - Belgio 75
RU - Federazione Russa 68
FR - Francia 30
IN - India 29
KR - Corea 28
IR - Iran 22
RO - Romania 21
TR - Turchia 12
BR - Brasile 11
NL - Olanda 9
CH - Svizzera 8
CA - Canada 7
CI - Costa d'Avorio 6
GR - Grecia 6
HK - Hong Kong 6
ES - Italia 5
AT - Austria 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
EU - Europa 3
ID - Indonesia 3
JP - Giappone 3
LB - Libano 3
PL - Polonia 3
AL - Albania 2
AR - Argentina 2
IQ - Iraq 2
LT - Lituania 2
PK - Pakistan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
SA - Arabia Saudita 1
TH - Thailandia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 8.071
Città #
Fairfield 666
Ashburn 459
Chandler 400
Woodbridge 399
Ann Arbor 353
Houston 323
Wilmington 312
Seattle 282
Cambridge 231
Palermo 186
Singapore 183
Jacksonville 122
Dublin 112
Nanjing 97
Medford 94
New York 82
Brussels 75
Princeton 62
Des Moines 60
Altamura 51
Boardman 51
San Diego 47
Dearborn 42
Lawrence 42
Tulsa 41
Ludwigshafen am Rhein 39
Shenyang 33
Santa Clara 32
Jinan 31
Kitzingen 29
Nanchang 27
Beijing 25
Seongnam 24
Tianjin 24
Helsinki 23
Venice 23
Changsha 22
Jiaxing 21
Falls Church 20
London 19
Kumar 18
Bremen 17
Munich 16
Ningbo 16
Tehran 15
Redwood City 14
Milan 13
Saint Petersburg 13
Hebei 12
Phoenix 12
Lancaster 11
San Mateo 11
Auburn Hills 10
Los Angeles 10
Rome 10
Guangzhou 9
Izmir 9
Lanzhou 9
Norwalk 9
Verona 9
San Paolo di Civitate 8
Taizhou 7
Abidjan 6
Aversa 6
Chicago 6
Hangzhou 6
Taiyuan 6
Zhengzhou 6
Columbus 5
Haikou 5
Hanover 5
Kunming 5
Pune 5
Shanghai 5
Washington 5
Chiswick 4
Frankfurt am Main 4
Naples 4
Stockholm 4
Tappahannock 4
Fuzhou 3
Hefei 3
Jinhua 3
Kilburn 3
Monreale 3
Moscow 3
Nürnberg 3
Ottawa 3
San Francisco 3
Shenzhen 3
Sofia 3
Agrigento 2
Atlanta 2
Baghdad 2
Barcelona 2
Brzeg 2
Busto Arsizio 2
Central District 2
Charlottesville 2
Chieti 2
Totale 5.564
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 276
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 216
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 205
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 205
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 202
Founder mutations in BRCA1 and BRCA2 genes 201
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 201
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 200
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 195
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 194
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 191
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 189
Liquid Biopsy in Breast Cancer 184
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 181
A headlight on liquid biopsies: a challenging tool for breast cancer management 179
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 172
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 167
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 163
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 161
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 160
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 158
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 158
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations during the follow-up: causal or casual association? 154
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 153
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 152
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 147
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 145
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 144
VUS variants in BRCA genes of hereditary breast/ovarian cancer 141
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 137
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 133
A missense mutation associated to early onset breast cancer in a sicilian woman. 128
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? 127
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 127
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 123
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 118
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors 116
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 115
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 114
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 106
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 103
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 95
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 94
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 94
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 93
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 91
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 90
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 89
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 89
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 85
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 84
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) 82
RUOLO DI P53 E DEI GENI K-RAS ED H-RAS NELLA TUMORIGENESI DEI CARCINOMI DELLE GHIANDOLE SALIVARI 81
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) 78
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 73
TP53 mutations are not prognostic indipendent indicators in bladder cancer 72
null 69
RUOLO DI P53 E DEI GENI K-RAS EDH-RAS NELLA TUMORIGENESI DELLE GHIANDOLE SALIVARI 66
Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia, severe visceromegaly and divergence between growth hormone and insulin-like growth factor-1 concentrations in acromegaly due to a therapeutically resistant pituitary GH-secreting macroadenoma 66
Impact of phospho-Akt expression on the clinical outcome and activity of gemcitabine and Akt inhibitors in pancreatic ductal adenocarcinoma 65
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 54
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 44
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 44
null 25
Totale 8.364
Categoria #
all - tutte 28.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.098 0 0 0 0 0 233 186 125 155 121 225 53
2020/20211.011 66 98 72 66 83 43 86 52 137 101 112 95
2021/2022867 60 182 25 39 43 37 66 41 87 101 57 129
2022/20231.146 117 202 27 152 141 166 54 88 133 9 42 15
2023/2024583 37 72 36 51 30 136 58 60 1 10 4 88
2024/2025428 22 78 66 130 73 59 0 0 0 0 0 0
Totale 8.364